AIA
PDLI

Arrow Investment Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Arrow Investment Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-156,295
Closed -$520K – 86
2016
Q1 		$520K Buy
156,295
+13,128
+9% +$40.9K 0.11% 59
2015
Q4 		$507K Sell
143,167
-54,008
-27% -$226K 0.13% 54
2015
Q3 		$992K Sell
197,175
-17,420
-8% -$99.8K 0.24% 39
2015
Q2 		$1.38M Buy
+214,595
New +$1.44M 0.28% 50

Other funds holding PDLI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM

Arrow Investment Advisors's PDLI Position: Q2 2016 in Review

Arrow Investment Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q2 2016, closing a stake of 156,295 shares — an estimated $520K sold.

Arrow Investment Advisors first reported a position in PDLI in Q2 2015 and held it in 4 quarters. The position peaked at $1.38M in Q2 2015. 201 funds tracked by Wall St. Rank hold PDLI as of Q2 2016.

  • Arrow Investment Advisors reported no remaining PDL BioPharma, Inc. position as of Q2 2016 after selling out during the quarter.
  • Arrow Investment Advisors sold 156,295 PDL BioPharma, Inc. shares in Q2 2016, an estimated $520K.
  • Arrow Investment Advisors first reported a position in PDL BioPharma, Inc. in Q2 2015 and held it in 4 quarters.
  • Arrow Investment Advisors's PDL BioPharma, Inc. position peaked at $1.38M in Q2 2015.
  • 201 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2016.

Based on Arrow Investment Advisors's 13F filing for Q2 2016, filed 28 Jul 2016.